Intra-Cellular Therapies Inc. (ITCI) Climbed 5.83% or 1.17 To Price $21.24 On Wednesday


Intra-Cellular Therapies Inc. (ITCI) climbed 5.83% or 1.17 to $21.24. It is around 183987 shares traded, which is 69.53% compare to the average total volume 264611. The market cap of ITCI is $1.16 billion. The year to date change is 38.22%. The 52 week price range is from $13.93 to $25.82. Price of ITCI have changed -11.78% during last week. It have changed -7.64% over last month, 12.94% over last 3 months, 3.59% over last 6 months and 29.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 21.14. It is -0.47% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for ITCI is 19.98. It is -5.93% below current price. The 52-week High is 25.82. It is 21.56% from the current price. The 52-week Low is 13.93. It is -34.42% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ITCI is 11.76 on 2018-09-14. Short % to float is 4.56%. There are some statistics of ITCI. It is has market cap $1.16 billion. The share outstanding is 54.71 million. The average volume is 264611. The revenue is 30754. The percent of top 15 Institution holding is 70.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -34.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -32.73%.


Tags:

Share this post